Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study

Archives of Internal Medicine
John G O'MearaStephen T Turner

Abstract

Two ethnically different, community-based samples of hypertensive adults were evaluated to determine the prevalence of dyslipidemia and how often dyslipidemia is drug-treated and controlled by such treatment. We studied 1286 non-Hispanic black hypertensive subjects from Jackson and 1070 non-Hispanic white hypertensive subjects from Rochester who participated in the Genetic Epidemiology Network of Arteriopathy study. Subjects were categorized according to presence of coronary heart disease and risk factors for coronary heart disease. Prevalence of dyslipidemia was significantly greater among whites than blacks (women, 64.7% vs 49.5%; and men, 78.4% vs 56.7%; P<.001 for both) and among men than women (P</=.02 in each ethnic group). Among dyslipidemic subjects, treatment with lipid-regulating drugs was significantly more common among whites than blacks (women, 25.4% vs 16.4%, P =.001; and men, 32.6% vs 12.8%; P<.001), and among whites, treatment was significantly more common among men than women (P =.03). With drug treatment, control of dyslipidemia varied from 33.9% (white men) to 51.9% (black men), but the differences among ethnic-sex groups were not statistically significant. Dyslipidemia is highly prevalent in hypertensive adu...Continue Reading

Citations

Apr 4, 2007·Postgraduate Medical Journal·Wang ShuSong Peng
Nov 10, 2007·The Journal of Clinical Investigation·Jun-ichi HanaiStewart H Lecker
May 2, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Peirang CaoStewart H Lecker
Nov 26, 2009·Patient Preference and Adherence·Richard H ChapmanCraig S Roberts
Nov 4, 2010·Current Atherosclerosis Reports·Sridevi DevarajIshwarlal Jialal
Dec 19, 2013·Vascular Health and Risk Management·Umar G AdamuAbidemi J Fasae
Mar 3, 2005·Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing·Berna G M SolFrank L J Visseren
Apr 6, 2007·Journal of Inherited Metabolic Disease·N M FisherG D Vladutiu
Sep 13, 2006·Current Hypertension Reports·Nitin Khosla, Henry R Black
Jun 1, 2010·Current Atherosclerosis Reports·Joshua Liao, John A Farmer
Dec 25, 2012·Human Genetics·Alexis C Frazier-WoodDonna K Arnett
Feb 9, 2012·Metabolic Syndrome and Related Disorders·Cassio José de Oliveira RodriguesMarcelo Costa Batista
Jan 5, 2011·Gender Medicine·Christine Maric
Jun 3, 2009·Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing·Diana K Eastridge
Dec 17, 2008·International Journal of Cardiology·Earl S FordAli H Mokdad
Dec 25, 2015·Journal of Clinical Lipidology·Terry A JacobsonUNKNOWN NLA Expert Panel
Apr 30, 2008·Journal of the Neurological Sciences·David S KnopmanStephen T Turner
Dec 13, 2007·Journal of Clinical Lipidology·Iftikhar J KulloStephen T Turner
Jan 5, 2008·The Journal of Clinical Hypertension·Joel Handler
Feb 19, 2008·British Journal of Clinical Pharmacology·Thomas M MacDonald, Steven V Morant
Nov 16, 2006·HIV Medicine·R BedimoD Margolis
May 6, 2008·The Journal of Clinical Hypertension·John B KostisUNKNOWN Treating to New Targets Steering Committee and Investigators
Aug 10, 2006·The Journal of Clinical Hypertension·Franz H MesserliUNKNOWN AVALON Investigators
Aug 20, 2010·American Journal of Human Biology : the Official Journal of the Human Biology Council·Sarinnapha VasunilashornCaleb E Finch
Apr 5, 2013·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Giuseppina Perrone, Roberto Brunelli
Oct 9, 2012·Muscle & Nerve·Giuseppe D'AntonaRoberto Bottinelli
Sep 4, 2007·The American Journal of Medicine·John B Kostis
Apr 10, 2010·Preventive Cardiology·Michael Miller
Jun 30, 2007·The American Journal of Cardiology·John B Kostis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.